Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

NCT02299089

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +17 more
Locations
  • Hospices Civils de Lyon Bron, France
  • CHU Rouen, Hôpital Charles Nicolle Rouen, France
  • Abteilung: Klinische Studien Bad Berka, Germany
  • Charité Campus Virchow Klinikum Berlin, Germany
View Trial Details
Completed

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

NCT02132468

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Markey Cancer Center, Clinical Research Office Lexington, Kentucky, United States
  • Montefiore The Bronx, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

NCT00381797

Conditions
Central Nervous System Diseases, Central Nervous System Neoplasms, Childhood Cerebral Anaplastic Astrocytoma, +22 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

NCT00667082

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +40 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • The Queen Elizabeth Hospital Woodville South, South Australia, Australia
  • Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia
View Trial Details

Related conditions